Retinoic acid inhibits osteogenic differentiation of rat bone marrow stromal cells

Biochemical and Biophysical Research Communications

Volumn 375, Issue 3, 2008, Pages 435-439

  Wang, Anxun ^a   Ding, Xueqiang ^a   Sheng, Shihu ^a   Yao, Zhaoyou ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adipogenesis; Bone marrow stromal cells; Bone morphogenetic protein (BMP); Differentiation; Osteogenesis; Retinoic acid; Signaling

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; OSTEONECTIN; RETINOIC ACID; SMAD5 PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; LIPID STORAGE; MALE; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROMA CELL;

ADIPOGENESIS; ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; MALE; OSTEOGENESIS; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD5 PROTEIN; STROMAL CELLS; TRETINOIN;

RATTUS;

EID: 50849121106     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.036     Document Type: Article

References (30)

1. Johansson S., Lind P.M., Hakansson H., Oxlund H., Orberg J., and Melhus H. Subclinical hypervitaminosis A causes fragile bones in rats. Bone 31 (2002) 685-689
2. Michaelsson K., Lithell H., Vessby B., and Melhus H. Serum retinol levels and the risk of fracture. N. Engl. J. Med. 348 (2003) 287-294
3. Saneshige S., Mano H., Tezuka K., Kakudo S., Mori Y., Honda Y., Itabashi A., Yamada T., Miyata K., Hakeda Y., et al. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem. J. 309 Pt 3 (1995) 721-724
4. Jacobson A., Johansson S., Branting M., and Melhus H. Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. Biochem. Biophys. Res. Commun. 322 (2004) 162-167
5. Parfitt A.M. The two faces of growth: benefits and risks to bone integrity. Osteoporos. Int. 4 (1994) 382-398
6. Bianco P., Riminucci M., Gronthos S., and Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
7. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., and Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
8. Ducy P., Schinke T., and Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289 (2000) 1501-1504
9. Teitelbaum S.L. Osteoclasts, integrins, and osteoporosis. J. Bone Miner. Metab. 18 (2000) 344-349
10. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 24 (2003) 218-235
11. Devlin R.D., Du Z., Pereira R.C., Kimble R.B., Economides A.N., Jorgetti V., and Canalis E. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144 (2003) 1972-1978
12. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., Kawabata M., Kato M., Ichijo H., and Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10 (1999) 3801-3813
13. Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
14. Wan D.C., Shi Y.Y., Nacamuli R.P., Quarto N., Lyons K.M., and Longaker M.T. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc. Natl. Acad. Sci. USA 103 (2006) 12335-12340
15. Warrell Jr. R.P. Retinoid resistance in acute promyelocytic leukemia: new mechanisms strategies and implications. Blood 82 (1993) 1949-1953
16. Zhou D.C., Kim S.H., Ding W., Schultz C., Warrell Jr. R.P., and Gallagher R.E. Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 99 (2002) 1356-1363
17. Deliloglu-Gurhan S.I., Vatansever H.S., Ozdal-Kurt F., and Tuglu I. Characterization of osteoblasts derived from bone marrow stromal cells in a modified cell culture system. Acta Histochem. 108 (2006) 49-57
18. Lian J.B., and Stein G.S. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit. Rev. Oral Biol. Med. 3 (1992) 269-305
19. Peter S.J., Liang C.R., Kim D.J., Widmer M.S., and Mikos A.G. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and l-ascorbic acid. J. Cell. Biochem. 71 (1998) 55-62
20. Hessle L., Johnson K.A., Anderson H.C., Narisawa S., Sali A., Goding J.W., Terkeltaub R., and Millan J.L. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA 99 (2002) 9445-9449
21. Anderson H.C., Sipe J.B., Hessle L., Dhanyamraju R., Atti E., Camacho N.P., and Millan J.L. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Pathol. 164 (2004) 841-847
22. Wagner E.F., and Karsenty G. Genetic control of skeletal development. Curr. Opin. Genet. Dev. 11 (2001) 527-532
23. Bi L.X., Simmons D.J., and Mainous E. Expression of BMP-2 by rat bone marrow stromal cells in culture. Calcif. Tissue Int. 64 (1999) 63-68
24. Nagasawa H., Takahashi S., Kobayashi A., Tazawa H., Tashima Y., and Sato K. Effect of retinoic acid on murine preosteoblastic MC3T3-E1 cells. J. Nutr. Sci. Vitaminol. (Tokyo) 51 (2005) 311-318
25. Lee C.I., Kohn D.B., Ekert J.E., and Tarantal A.F. Morphological analysis and lentiviral transduction of fetal monkey bone marrow-derived mesenchymal stem cells. Mol. Ther. 9 (2004) 112-123
26. Skillington J., Choy L., and Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J. Cell Biol. 159 (2002) 135-146
27. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., Toriyabe T., Kawabata M., Miyazono K., and Kato S. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283 (1999) 1317-1321
28. Helvering L.M., Sharp R.L., Ou X., and Geiser A.G. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 256 (2000) 123-138
29. Choy L., Skillington J., and Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J. Cell Biol. 149 (2000) 667-682
30. Akiyama S., Katagiri T., Namiki M., Yamaji N., Yamamoto N., Miyama K., Shibuya H., Ueno N., Wozney J.M., and Suda T. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp. Cell Res. 235 (1997) 362-369